Carnegie acted as sole financial adviser in the directed new share issue of 2.25 million new Class B shares at a price of SEK 122.50 per share. Recipharm provides contract manufacturing and development services for other pharmaceutical companies. Manufacturing primarily involves production of pharmaceuticals in various forms.January 2016.
Healthcare
Directed new share issue in Recipharm (SE) — SEK 276 million
January 2016